| Literature DB >> 30779516 |
Norfazillah Ab Manan1, Azimatun Noor Aizuddin1, Rozita Hod1.
Abstract
IntroductionMany epidemiological studies have demonstrated associations between air pollution levels and human health in terms of hospital admissions. The aim of this paper is to gather evidence concerning air pollution effects on the risk of hospital admission. We hypothesised that increase in: particulate matter (PM), ozone (O3), carbon monoxide (CO), nitrogen dioxide (NO2), and sulphur dioxide (SO2) levels would be associated with the increasing trend of hospital admission.MethodsA systematic review of literature was carried out. Literature search was done in Sage, Ovid Medline, Science Direct, Wiley and ProQuest from 2010 to 2016 using keywords "hospital admission and air pollution". Studies of any relevant design were included if they presented original data, included at least one analysis where hospital admission was the specific outcome, and one or more of the following exposures were investigated: PM, O3, CO, NO2 and SO2.ResultsA total of 175 potential studies were identified by the search. Twenty two studies qualified for the review. Air pollution was noted to have an excessive risk of 3.46 (95%CI, 1.67, 5.27) of total hospital admissions. Cardiovascular admission was noted to have an increased risk of hospitalization for PM2.5 of 1.5 to 2.0; PM10 (1.007 to 2.7); NO2 (1.04 to 1.17) and SO2 (1.007). For respiratory admission, PM2.5 can caused an increased risk of hospitalization by 1.1 to 1.8; PM10 (1.007 to 1.13); NO2 (1.08 to 1.94) and SO2 (1.02). While O3 have minimal effect on COPD and stroke, CO does not influence in the effect of these hospitalization.ConclusionThe exposure to air pollutants confers an increased risk of admission of several disease. Our findings call for greater awareness of environmental protection and the implementation of effective measures to improve the quality of air, which may reduce the risks of adverse effects on the population's health.Entities:
Mesh:
Year: 2018 PMID: 30779516 PMCID: PMC6748301 DOI: 10.9204/aogh.2376
Source DB: PubMed Journal: Ann Glob Health ISSN: 2214-9996 Impact factor: 2.462
Figure 1Search results and selection of studies for systematic review.
Studies that were involved in this systemic review.
| No | Study | Study period | Location | Study design | Health effect |
|---|---|---|---|---|---|
| 1 | Montresor-López et al. 2015 [ | 2002–2006 | US | Case-crossover | Stroke admission |
| 2 | Cheng et al. 2015 [ | 2006–2010 | Taiwan | Case-crossover | COPD admission |
| 3 | Milojevic et al. 2014 [ | 2003–2009 | England | Case-crossover | CVS admission |
| 4 | Iskandar et al. 2011 [ | 2001–2008 | Denmark | Case-crossover | Asthma admission |
| 5 | Ghozikali et al. 2015 [ | 2008–2009 | Iran | Case-crossover | COPD admission |
| 6 | Wong et al. 2016 [ | 1998–2001 | Hong Kong | Cohort | Peptic ulcer admission |
| 7 | Tonne et al. 2016 [ | 2003–2007 | London | Cohort | Readmission of Myocardial infarction |
| 8 | Atkinson et al. 2014 [ | 2003–2007 | London | Cohort | COPD admission |
| 9 | Andersen et al. 2011 [ | 1993–2006 | Denmark | Cohort | COPD admission |
| 10 | Andersen et al. 2012 [ | 1993–2007 | Denmark | Cohort | Asthma admission |
| 11 | Alimohammadi et al. 2016 [ | 2012–2013 | Iran | Retrospective cross sectional | Ischaemic stroke admission |
| 12 | Mansourian et al. 2010 [ | 2005–2006 | Iran | Retrospective cross sectional | Respiratory admission |
| 13 | Ferreira et al. 2016 [ | 2010–2011 | Brazil | Times-series | Respiratory admission |
| 14 | Phung et al. 2016 [ | 2004–2007 | Vietnam | Times-series | Respiratory admission |
| 15 | Vidotto et al. 2012 [ | 2000–2007 | Brazil | Times-series | Paediatric rheumatic diseases admission |
| 16 | Kollanus et al. 2016 [ | 2001–2010 | Finland | Times-series | CVS admission |
| 17 | Oudin et al. 2010 [ | 2001–2005 | Sweden | Times-series | Ischaemic stroke admission |
| 18 | Vidale et al. 2010 [ | 2000–2003 | Italy | Times-series | Ischaemic stroke admission |
| 19 | Jevtić et al. 2014 [ | 2007–2009 | Serbia | Times-series | CVS admission |
| 20 | Xie et al. 2014 [ | 2010–2012 | China | Times-series | IHD admission |
| 21 | Zhang et al. 2014 [ | 2008–2011 | China | Times-series | Hospital admission |
| 22 | Chen et al. 2016 [ | 2003–2013 | Adelaide | Times-series & case-crossover | Asthma admission |
Note: CVS: Cardiovascular; IHD: Ischaemic Heart Disease; COPD: Chronic Obstructive Pulmonary Disease.
Effect of the pollutant to hospitalization.
| Pollutant | Health effect | RR/OR/HR (95% CI) | Study design | Study |
|---|---|---|---|---|
| PM2.5 | Respiratory admission | RR 8.5% (–6.8, 26.3) | TS | Ferreira et al. 2016 |
| RR 10.5% (–2.2, 24.8) | TS | Kollanus et al. 2016 | ||
| Asthma admission | RR 30.2% (13.4, 49.6) | TS & CCO | Chen et al. 2016 | |
| OR 1.09 (1.04, 1.13) | CCO | Iskandar et al. 2011 | ||
| OR 1.10 (1.06, 1.13) | CCO | Cheng et al. 2015 | ||
| COPD Admission | OR 1.11 (1.09, 1.13) | CCO | Cheng et al. 2015 | |
| HR 1.05 (0.98, 1.13) | Cohort | Atkinson et al. 2014 | ||
| Pneumonia admission | OR 1.12 (1.11, 1.13) | CCO | Cheng et al. 2015 | |
| CVS Admission | RR 19.6% (6.4, 34.6) | TS | Ferreira et al. 2016 | |
| RR 1.5% (–6.9, 10.6) | TS | Kollanus et al. 2016 | ||
| Ischaemic stroke | RR 1.09 (1.03, 1.15) | RCS | Alimohammadi et al. 2016 | |
| IHD admission | RR 0.27% (0.21, 0.33) | TS | Xie et al. 2014 | |
| MI admission | HR 1.02 (0.98, 1.06) | Cohort | Tonne et al. 2016 | |
| PUD admission | HR 1.18 (1.02, 1.36) | Cohort | Wong et al. 2016 | |
| Gastric ulcer | HR 1.29 (1.09, 1.53) | |||
| Duodenal ulcer | HR 0.98 (0.78, 1.22) | |||
| PM10 | Respiratory admission | RR 12.8% (6.0, 20.0) | TS | Ferreira et al. 2016 |
| β coefficient = 0.63; p < 0.001) | RCS | Mansourian et al. 2010 | ||
| RR 1.007 (1.002, 1.013) | TS | Phung et al. 2016 | ||
| Asthma admission | RR 8.3% (2.5, 14.4) | TS & CCO | Chen et al. 2016 | |
| OR 1.04 (1.03–1.06) | CCO | Cheng et al. 2015 | ||
| OR 1.07 (1.03, 1.12) | CCO | Iskandar et al. 2011 | ||
| COPD Admission | OR 1.05 (1.03–1.06) | CCO | Cheng et al. 2015 | |
| Pneumonia admission | OR 1.05 (1.04–1.05) | CCO | Cheng et al. 2015 | |
| CVS Admission | RR 2.7% (–2.2, 7.9) | TS | Ferreira et al. 2016 | |
| RR 1.005 (1, 1.009) | TS | Phung et al. 2016 | ||
| Ischaemic stroke | RR 1.14 (1.06, 1.22) | RCS | Alimohammadi et al. 2016 | |
| RR 13% (4, 22) | TS | Oudin et al. 2010 | ||
| RR 1.078 (1.104, 1.052) | TS | Vidale et al. 2010 | ||
| MI admission | HR 1.05 (1.00, 1.10) | Cohort | Tonne et al. 2016 | |
| NO2 | Respiratory admission | RR 1.08 (1.06, 1.011) | TS | Phung et al. 2016 |
| RR 1.94 (0.50, 3.40) | TS | Zhang et al. 2014 | ||
| Asthma admission | RR 12.5% (6.6, 18.7), | TS & CCO | Chen et al. 2016 | |
| HR 1.12 (1.04, 1.22) | Cohort | Andersen et al. 2012 | ||
| OR 1.10 (1.04, 1.16) | CCO | Iskandar et al. 2011 | ||
| COPD Admission | HR 1.06 (0.98, 1.15) | Cohort | Atkinson et al. 2014 | |
| HR 1.08 (1.02, 1.14) | Cohort | Andersen et al. 2011 | ||
| OR 1.0038 (1.0004, 1.0094) | CCO | Ghozikali et al. 2015 | ||
| CVS Admission | RR 1.04 (1, 1.06) | TS | Phung et al. 2016 | |
| RR 1.049 (1.009, 1.091) | TS | Jevtić et al. 2014 | ||
| OR 1.7% (95% CI 0.9 to 2.6) | CCO | Milojevic et al. 2014 | ||
| Ischaemic stroke | RR 1.07 (1.04, 1.1) | RCS | Alimohammadi et al. 2016 | |
| RR 1.039 (1.066, 1.013) | TS | Vidale et al. 2010 | ||
| MI admission | HR 1.05 (0.99, 1.10) | Cohort | Tonne et al. 2016 | |
| SO2 | Respiratory admission | RR 1.02 (1.01, 1.03) | TS | Phung et al. 2016 |
| β coefficient = 0.59; p < 0.001) | RCS | Mansourian et al. 2010 | ||
| COPD admission | OR 1.0044 (1, 1.011) | CCO | Ghozikali et al. 2015 | |
| CVS Admission | RR 1.007 (1, 1.01) | TS | Phung et al. 2016 | |
| Ischaemic stroke | RR 1.08 (1.06, 1.1) | RCS | Alimohammadi et al. 2016 | |
| Paediatric rheumatic diseases | RR 1.98% (0.25, 3.69) | TS | Vidotto et al. 2012 | |
| Ozone | COPD admission | RR 1.0058 (1.0022, 1.0094) | CCO | Ghozikali et al. 2015 |
| Ischaemic stroke | RR 1.07 (1.03, 1.11) | RCS | Alimohammadi et al. 2016 | |
| Stroke admission | OR 0.98 (0.96, 1.00) | CCO | Montresor-López et al. 2015 | |
Note: CVS: Cardiovascular; IHD: Ischaemic Heart Disease; COPD: Chronic Obstructive Pulmonary Disease; MI: Myocardial infarction; PUD: Peptic Ulcer Disease.
The disease and the pollutant that effect the admission.
| Diseases | Pollutant | Study | Study design | Effect |
|---|---|---|---|---|
| Asthma | PM2.5 | Chen et al. 2016 | TS & CCO | RR 30.2% (13.4, 49.6) |
| Cheng et al. 2015 | CCO | OR 1.10 (1.06, 1.13) | ||
| Iskandar et al. 2011 | CCO | OR 1.09 (1.04, 1.13) | ||
| PM10 | Chen et al. 2016 | TS & CCO | RR 8.3% (2.5, 14.4) | |
| Cheng et al. 2015 | CCO | OR 1.04 (1.03–1.06) | ||
| Iskandar et al. 2011 | CCO | OR 1.07 (1.03, 1.12) | ||
| NO2 | Chen et al. 2016 | TS & CCO | RR 12.5% (6.6, 18.7), | |
| Iskandar et al. 2011 | CCO | OR 1.10 (1.04, 1.16) | ||
| Andersen et al. 2012 | Cohort | HR 1.12 (1.04, 1.22) | ||
| COPD | PM2.5 | Cheng et al. 2015 | CCO | OR 1.11 (1.09, 1.13) |
| Atkinson et al. 2014 | Cohort | HR 1.05 (0.98, 1.13) | ||
| PM10 | Cheng et al. 2015 | CCO | OR 1.05 (1.03–1.06) | |
| NO2 | Atkinson et al. 2014 | Cohort | HR 1.06 (0.98, 1.15) | |
| Andersen et al. 2011 | Cohort | HR 1.08 (1.02, 1.14) | ||
| Ghozikali et al. 2015 | CCO | RR 1.0038 (1.0004, 1.0094) | ||
| SO2 | Ghozikali et al. 2015 | CCO | RR 1.0044 (1, 1.011) | |
| Ozone | Ghozikali et al. 2015 | CCO | RR 1.0058 (1.0022, 1.0094) | |
| Pneumonia | PM2.5 | Cheng et al. 2015 | CCO | OR 1.12 (1.11, 1.13) |
| PM10 | Cheng et al. 2015 | CCO | OR 1.05 (1.03–1.06) | |
| Ischaemic stroke | PM2.5 | Hossein | RCS | RR 1.09 (1.03, 1.15) |
| PM10 | Alimohammadi et al. 2016 | RCS | RR 1.14 (1.06, 1.22) | |
| Oudin et al. 2010 | TS | RR 13% (4, 22) | ||
| Vidale et al. 2010 | TS | RR 1.078 (1.104, 1.052) | ||
| NO2 | Alimohammadi et al. 2016 | RCS | RR 1.07 (1.04, 1.1) | |
| Vidale et al. 2010 | TS | RR 1.039 (1.066, 1.013) | ||
| SO2 | Alimohammadi et al. 2016 | RCS | RR 1.08 (1.06, 1.1) | |
| Ozone | Alimohammadi et al. 2016 | RCS | RR 1.07 (1.03, 1.11) | |
| Montresor-López et al. 2015 | CCO | OR 0.98 (0.96, 1.00) | ||